Tirzepatide vs Semaglutide
How the two medicines differ in mechanism, published trial results and side effects. A2Z offers compounded tirzepatide only; it does not offer semaglutide.
Last reviewed 2026-10-04 by Jack Mayeux, APRN, FNP. This page is clinical content and is reviewed on a regular schedule.
A2Z's tirzepatide is a compounded medication. Compounded drugs are not FDA-approved and are not commercially manufactured products. Prepared by a licensed pharmacy when prescribed. It is not Zepbound, Mounjaro, Wegovy or Ozempic, and the trials below used brand-name products, not compounded tirzepatide.
| Factor | Tirzepatide | Semaglutide |
|---|---|---|
| Mechanism | Dual GLP-1 + GIP receptor agonist | GLP-1 receptor agonist |
| Route | Subcutaneous injection | Injection (and oral form available) |
| GI side-effect profile | More diarrhea, less nausea | More nausea, more constipation |
| At A2Z | Compounded medication; separate product, $249 per fill | Not offered by A2Z |
How they work
Semaglutide is a GLP-1 receptor agonist — it mimics the hormone that signals fullness and slows stomach emptying. Tirzepatide goes further: it is a dual GIP and GLP-1 receptor agonist, targeting two incretin pathways at once. That dual action is how the two medicines differ in how they work. Both suppress appetite and reduce "food noise," and both are taken on a gradual titration schedule to manage gastrointestinal side effects.
What the SURMOUNT-5 trial showed
A head-to-head trial of the FDA-approved brand-name products has been published (SURMOUNT-5, N Engl J Med 2025). Its results apply only to the brand-name products studied. Compounded tirzepatide is not FDA-approved, is not the same as any FDA-approved drug, and has not been studied in clinical trials. A licensed provider can review whether any option is appropriate for you.
Source: Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26–36.
Side-effect differences
Both are gastrointestinal. Semaglutide tends toward nausea and constipation; tirzepatide more commonly causes diarrhea with less nausea. Side effects are dose-dependent and usually worst during titration and after dose increases. Both carry a warning for men with a personal or family history of medullary thyroid carcinoma or MEN 2.
How to choose
This is not as simple as "tirzepatide wins." Semaglutide has a larger long-term cardiovascular outcomes dataset (the SELECT trial) and an oral form, which some men prefer. The right choice depends on your weight-loss goal, your tolerance for GI side effects, your cardiovascular history, and whether an oral option matters to you. Your provider helps you decide based on your actual situation. A2Z's tirzepatide is a compounded medication and a separate standalone product, priced independently from the $149/mo TRT program.
Talk to a provider about medical weight loss
A free video consult, comprehensive labs, and an honest answer on whether compounded tirzepatide is appropriate for you. Your provider decides, never a generic menu.
